Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

ADMA Biologics Inc - Common Stock (NQ:ADMA)

9.380 -0.140 (-1.47%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 25, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	3,566,731
Open	9.550
Bid (Size)	9.060 (100)
Ask (Size)	9.530 (300)
Prev. Close	9.520
Today's Range	9.230 - 9.625
52wk Range	7.210 - 20.46
Shares Outstanding	196,357,149
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with SBS Law

August 10, 2026

From Schall, Brown & Schwartz LLP

Via Business Wire

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026

August 10, 2026

From Faruqi & Faruqi, LLP

Via Business Wire

Performance

YTD	-47.5%	-47.5%
1 Month	-1.1%	-1.1%
3 Month	+12.1%	+12.1%
6 Month	+2.5%	+2.5%
1 Year	-39.9%	-39.9%

More News

ADMA DEADLINE TOMORROW: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA

August 09, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

ADMA Biologics 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA

August 07, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

ADMA Biologics (NASDAQ:ADMA) Shares Slide as Q2 Results Miss Estimates ↗

August 05, 2026

Via Chartmill

ADMA BIOLOGICS CLASS ACTION DEADLINE AUGUST 10th: Bragar Eagel & Squire, P.C. Urges ADMA Biologics, Inc. Stockholders to Contact the Firm Regarding Their Rights Before August 10th

August 07, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

August 07, 2026

Via Newsfile

ADMA Biologics Deadline: Rosen Law Firm Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA

August 07, 2026

From The Rosen Law Firm, P.A.

Via Business Wire

ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA

August 07, 2026

From SkyMedia, LLC

Via GlobeNewswire

ADMA BIOLOGICS DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA

August 06, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with SBS Law

August 06, 2026

From Schall, Brown & Schwartz LLP

Via GlobeNewswire

ADMA Biologics Q2 Earnings Call Highlights ↗

August 05, 2026

Via MarketBeat

ADMA Biologics Reports Second Quarter 2026 Financial Results and Provides Business Update

August 05, 2026

From ADMA Biologics, Inc.

Via GlobeNewswire

ADMA Biologics (ADMA) Shareholder Alert: Kehoe Law Firm Investigates Potential Fiduciary Duty Breaches

August 05, 2026

Via Newsfile

DEADLINE NEXT WEEK: Berger Montague Advises ADMA Biologics, Inc. (NASDAQ: ADMA) Investors to Contact the Firm Before August 10, 2026

August 05, 2026

From Berger Montague

Via GlobeNewswire

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

August 04, 2026

From Kahn Swick & Foti, LLC

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ADMA Biologics, Inc. of Class Action Lawsuit and Upcoming Deadlines – ADMA

August 04, 2026

From Pomerantz LLP

Via GlobeNewswire

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against ADMA Biologics, Inc. (ADMA)

August 04, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

ADMA BIOLOGICS CLASS ACTION DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges ADMA Biologics, Inc. Stockholders to Contact the Firm Regarding Their Rights Before August 10th

August 03, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

August 03, 2026

Via Newsfile

ADMA BIOLOGICS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA

August 03, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with SBS Law

August 03, 2026

From Schall, Brown & Schwartz LLP

Via GlobeNewswire

ADMA DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA

July 31, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

July 31, 2026

Via Newsfile

ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.

July 31, 2026

From Lowey Dannenberg, P.C.

Via GlobeNewswire

Frequently Asked Questions

Is ADMA Biologics Inc - Common Stock publicly traded?

Yes, ADMA Biologics Inc - Common Stock is publicly traded.

What exchange does ADMA Biologics Inc - Common Stock trade on?

ADMA Biologics Inc - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for ADMA Biologics Inc - Common Stock?

The ticker symbol for ADMA Biologics Inc - Common Stock is ADMA on the Nasdaq Stock Market

What is the current price of ADMA Biologics Inc - Common Stock?

The current price of ADMA Biologics Inc - Common Stock is 9.380

When was ADMA Biologics Inc - Common Stock last traded?

The last trade of ADMA Biologics Inc - Common Stock was at 09/25/26 04:00 PM ET

What is the market capitalization of ADMA Biologics Inc - Common Stock?

The market capitalization of ADMA Biologics Inc - Common Stock is 1.84B

How many shares of ADMA Biologics Inc - Common Stock are outstanding?

ADMA Biologics Inc - Common Stock has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.